Company Information

Freyherr International Group plc

Incorporated in: England & Wales
Company Number: 11160911
Legal Entity Identifier: 213800XMPEIC8VQYNF95

Registered Office:

No. 1 London Bridge
London
SE1 9BG

Group Profile

Freyherr International Group plc is the UK parent company of a group engaged in the production of medicinal cannabis products. The group is committed to research, development, cultivation, processing and production of APIs, final products and dosing packaging. Operations are centered in Slovenia and the Group principally operates within the EU.

Patron d.o.o. is the dispenser arm which has been operating since 2015. It develops, produces and markets products suitable for dosing concentrates and extracts. The company also offers analytical services for determination of cannabinoid content (CBD, THC and 11 other cannabinoids) in a given material, from dried plant material to its extracts, concentrates or finished products.

Freyherr Pharma d.o.o. is the pharmaceutical arm of the Group and holds an EU GMP certificate. It operates from a certified production facility, manufactures CBD products for the Group and produces white label CBD products supplying them to various EU countries. Its Quality assurance department is specialized
in EU pharmaceutical quality system, considering cannabis specifics. An important strength of Freyherr Pharma is also a Research and development department with remarkable expertise in the cultivation, processing, formulation and legal and regulatory compliance of cannabis-based products. Freyherr Pharma is currently growing cannabis varieties from EU Plant database in Slovenia and has invested in cannabis production facilities in other jurisdictions.

Share Information

Number of Ordinary Shares in Issue:
25,763,868 ordinary shares of ￡0.01 each
ISIN: GB00BJK3K011
SEDOL: BJK3K01
Ticker: FRYR

Directors’ shareholdings

Ordinary shares

Name	No. of Ordinary Shares	% holding


Eva Tavčar Benkovič	3,535,353	13.72 %
Boris Eržen¹	2,383,017	9.24 %
Tony Burke	Nil	0.00 %
		22,96 %

¹ Mr. Erzen’s shareholding is held by Gedala Limited, incorporated in Cyprus, and its wholly-owned subsidiary Avemontis d.o.o., incorporated in Slovenia. Mr Eržen is the ultimate beneficial owner of Gedala

Material Shareholdings (3% or above)

Ordinary shares

Name	No. of Ordinary Shares	% holding
Beautiful Things Foundation	6,553,300	25.42%
Marko Rogl	2,911,567	11.29%
Luka Freyer	2,320,515	9.00%
Tomaz Frelih	1,547,010	6.00%
Massimo Rojac2	956,490	3.71%

Shares in Public hands

2 Mr Rojac’s shareholding is held by Olium d.o.o., a company of which he is the sole shareholder.

The information in this section was last updated on 8^thSeptember 2020.

There are no restrictions on the transfer of shares.

WARRANTS:
There are a total of 257,639 warrants in existence of various prices and exercise dates.

Corporate Governance

Executive Directors

Eva Tavčar Benković

Technical Director

Age 33

Eva has a Master of Pharmacy degree and a PhD in biomedicine from the University of Ljubljana. She specialises in phytochemistry and the effects and quality of herbal medicinal drugs and has been researching and developing herbal medicines, food supplements and cosmetic products for over 10 years. She remains a researcher and assistant professor at the University.

Her particular interest in cannabis research and its medicinal properties began when she developed an analytical method for the determination of cannabinoid content. She has held a community pharmacist licence since 2010 and she is acknowledged as an expert in her field and has contributed to peer-review scientific papers, some book chapters and various articles on cannabinoids.

She is responsible for technological development of Freyherr, and oversees the activities of experts in the fields of agronomy, chemistry, pharmacy, compliance and medicinal impact, and covers development of methods of production from seeds to the constituents of the final products.

ERVIN URŠIČ KOVAČ

Director

Age 29

A graduate of The Faculty of Law in Ljubljana, Ervin began his career in banking, before joining Cashila OOD s.r.o, which at that time was the first licensed EU blockchain company. The company grew rapidly, so much so that Cashila created a spin off company in which Ervin was appointed Chief Operating Officer, a position he held until December 2017. During his time as COO, the company grew to more than 40 employees and a 400m EUR valuation.

In 2018, Ervin was entrusted to liquidate and redistribute all the assets of a blockchain company, which at that time amounted to more than EUR10M. The following year he joined Freyherr Pharma to assist the management team, initially on a consulting basis, and subsequently as interim COO.

Ervin’s previous work responsibilities have been focused on the operational and technical needs of start-up and scale-up companies. His experience of working with service providers to improve processes and collaborating to streamline operations has made him a driving force that ensures the business, and all of its moving parts, are running smoothly. He brings a diversity of knowledge and experience, combined with adaptability which fits the fast paced environment of medicinal cannabis.

Non-Executive Team

Boris Eržen

Non-executive

Age 41

Boris Eržen originally trained as a lawyer and has a LL.B from the Faculty of Law, University of Ljubljana and a LL.M. from University of London. He has worked in start-ups for the last 14 years as a general counsel, mainly in the IT industry where he has managed all legally related activities of quickly growing companies, including preparation for the entry of professional investors.

At Slovenian search-engine Najdi.si he developed the legal function to support over 100 employees and enable its sale to local telco Telekom Slovenije for more than €10 million. In2011 he joined Outfit7 as general counsel and helped make the “Talking Tom” franchise a multi-billion download hit with over 200 employees, The company was sold to a consortium of Chinese investors under leadership of United Luck for US $1 billion in 2016. His expertise principally lies in corporate structuring, IP protection, contract negotiation and building a legal function in a start-up in a way which facilitates exponential growth while ensuring legal compliance throughout the organisation.

Tony Burke -

Non-executive Chairman

Age 59

Tony Burke started his career in the City of London in the late 1970’s on the floor of the London Stock Exchange as a ‘stockjobber’ and was made an ‘individual’ member of the London Stock Exchange in 1985. Tony has spent the last 40+ years serving as either principal or director in both established and emerging investment firms within the areas of fund management, proprietary trading, stock broking, and investor relations.

Over his long career Tony has built strong, broad-based relationships with buy-side institutions, fund managers, sell-side analysts, investment banks, family offices, and professional investors. He has also worked – as a director and/or principal – on three different continents.

Some of the areas he has been active in are: Social Impact Investment; Renewable Energy; Long/Short equity strategies; Infrastructure; Cash and Cash Equivalents; FinTech, Real Estate; Specialist Investments.
p
p